Rev generating; addressing peripheral nerve repair w portfolio of regenerative medicine products in US, Canada et al. Products incl. Avance Nerve Graft: off-the-shelf commercially avail processed human nerve allograft bridging severed nerves w/o comorbidities assoc w addl surgical site. 3Q18 revenue ($22.7M), up 41% vs $16M (3Q17).
Marketed, Phase III
Central Nervous System, Pain
Biotechnology, Medical Device
13631 Progress Blvd
Alachua, FL 32615
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by